| CSMD3 altered in cohorts of …ALTERED_INderived32 of 32show fewer |
|---|
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 387 / 528 cases (73 %) · ssm · TCGA-HNSC · largest of 5 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 5 | Observed | gdc | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 212 / 293 cases (72 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Carcinoma 130 / 185 cases (70 %) · ssm · TCGA-ESCA | — | — | Esophageal Carcinoma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 305 / 443 cases (69 %) · ssm · TCGA-STAD · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | gdc | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 383 / 573 cases (67 %) · ssm · TCGA-LUAD · largest of 9 cohorts | — | — | Lung Adenocarcinoma | 9 | Observed | gdc | graph → |
| → altered in cohorts of | Endometrial Carcinoma 277 / 559 cases (50 %) · ssm · TCGA-UCEC · largest of 5 cohorts | — | — | Endometrial Carcinoma | 5 | Observed | gdc | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 39 / 83 cases (47 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Osteosarcoma 65 / 145 cases (45 %) · ssm · TARGET-OS | — | — | Osteosarcoma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 209 / 484 cases (43 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 5 cohorts | — | — | Lung Squamous Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 477 / 1,144 cases (42 %) · ssm · nsclc_tcga_broad_2016 · largest of 3 cohorts | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Small Cell Carcinoma 42 / 120 cases (35 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 141 / 469 cases (30 %) · ssm · skcm_tcga_gdc · largest of 7 cohorts | — | — | Cutaneous Melanoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 39 / 144 cases (27 %) · ssm · mel_dfci_2019 · largest of 2 cohorts | — | — | Melanoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Carcinoma, Other 27 / 108 cases (25 %) · ssm · ohnca_cptac_gdc | — | — | Head and Neck Carcinoma, Other | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 121 / 518 cases (23 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 40 / 185 cases (22 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 80 / 429 cases (19 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 46 / 247 cases (19 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 65 / 494 cases (13 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Acute Myeloid Leukemia 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Combined Hepatocellular Carcinoma and Cholangiocarcinoma 21 / 173 cases (12 %) · ssm · hccihch_pku_2019 | — | — | Combined Hepatocellular Carcinoma and Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 48 / 474 cases (10 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 100 / 1,015 cases (9.9 %) · ssm · crc_sysucc_2022 · largest of 5 cohorts | — | — | Colorectal Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 34 / 352 cases (9.7 %) · ssm · rcc_cptac_gdc · largest of 2 cohorts | — | — | Renal Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 69 / 755 cases (9.1 %) · ssm · mbn_mdacc_2013 · largest of 2 cohorts | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 84 / 961 cases (8.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Diffuse Glioma 54 / 629 cases (8.6 %) · ssm · difg_glass · largest of 2 cohorts | — | — | Diffuse Glioma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 34 / 417 cases (8.2 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 22 / 291 cases (7.6 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | High-Grade Serous Ovarian Cancer 38 / 523 cases (7.3 %) · ssm · ov_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | High-Grade Serous Ovarian Cancer | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 27 / 379 cases (7.1 %) · ssm · brca_mbcproject_2022 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 61 / 1,013 cases (6.0 %) · ssm · prad_p1000 · largest of 2 cohorts | — | — | Prostate Adenocarcinoma | 2 | Observed | cbioportal | graph → |